Heartbeam Inc (BEAT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Heartbeam Inc (BEAT) has a cash flow conversion efficiency ratio of -1.116x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.91 Million) by net assets ($2.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Heartbeam Inc - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Heartbeam Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Heartbeam Inc (BEAT) total liabilities for a breakdown of total debt and financial obligations.
Heartbeam Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Heartbeam Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Banswara Syntex Limited
NSE:BANSWRAS
|
0.035x |
|
Nsys Co. Ltd.
KQ:333620
|
0.014x |
|
Amplia Therapeutics Ltd
AU:ATX
|
-0.178x |
|
Cettire Ltd
AU:CTT
|
-1.619x |
|
Gunawan Dianjaya Steel Tbk
JK:GDST
|
-0.031x |
|
Unibios Holdings S.A
AT:BIOSK
|
0.021x |
|
NDL Ventures Limited
NSE:NDLVENTURE
|
0.000x |
|
TOP Engineering Co. Ltd
KQ:065130
|
0.098x |
Annual Cash Flow Conversion Efficiency for Heartbeam Inc (2006–2025)
The table below shows the annual cash flow conversion efficiency of Heartbeam Inc from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Heartbeam Inc (BEAT) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.60 Million | $-13.99 Million | -5.374x | +38.58% |
| 2024-12-31 | $1.65 Million | $-14.47 Million | -8.749x | -1053.02% |
| 2023-12-31 | $15.94 Million | $-12.09 Million | -0.759x | +81.89% |
| 2022-12-31 | $2.37 Million | $-9.95 Million | -4.190x | -1639.73% |
| 2021-12-31 | $13.41 Million | $-3.23 Million | -0.241x | -292.09% |
| 2020-12-31 | $-4.79 Million | $-600.00K | 0.125x | +114.37% |
| 2019-12-31 | $-3.73 Million | $-218.00K | 0.058x | -75.04% |
| 2018-12-31 | $310.49 Million | $72.75 Million | 0.234x | +146.00% |
| 2017-12-31 | $249.70 Million | $23.78 Million | 0.095x | -65.95% |
| 2016-12-31 | $138.91 Million | $38.85 Million | 0.280x | +47.98% |
| 2015-12-31 | $75.93 Million | $14.35 Million | 0.189x | +36.59% |
| 2014-12-31 | $63.68 Million | $8.81 Million | 0.138x | -17.87% |
| 2013-12-31 | $66.83 Million | $11.26 Million | 0.168x | +105.34% |
| 2012-12-31 | $70.00 Million | $5.74 Million | 0.082x | +27.22% |
| 2011-12-31 | $78.00 Million | $5.03 Million | 0.064x | -16.03% |
| 2010-12-31 | $134.93 Million | $10.36 Million | 0.077x | +45.11% |
| 2009-12-31 | $149.35 Million | $7.90 Million | 0.053x | -22.93% |
| 2008-12-31 | $150.12 Million | $10.31 Million | 0.069x | +676.27% |
| 2007-12-31 | $-26.87 Million | $-237.64K | 0.009x | -93.97% |
| 2006-12-31 | $-19.86 Million | $-2.91 Million | 0.147x | -- |
About Heartbeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection … Read more